Form 4 for VTAK Catheter Precision, Inc.
Accepted 2025-12-08 00:00:00 ET · period of report 2025-12-05 · accession 0001437749-25-037162 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2025-12-08 | 2025-12-05 | VTAK | JENKINS DAVID A | COB, CEO | C - Cnv Deriv | $0.00 | +30.9K | 109 | New | $0 |
| D | 2025-12-08 | 2025-12-05 | VTAK | JENKINS DAVID A | COB, CEO | C - Cnv Deriv | $0.00 | +12.1K | 13.8K | +695% | $0 |
| DMI | 2025-12-08 | 2025-12-05 | VTAK | JENKINS DAVID A | COB, CEO | C - Cnv Deriv | $0.00 | -5,879 | 0 | -100% | $0 |
| D | 2025-12-08 | 2025-12-05 | VTAK | JENKINS DAVID A | COB, CEO | C - Cnv Deriv | $0.00 | -2,292 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-05 | C | A | 30,844 | $0.00 | 34,579 | I See Footnote | — | — | (F2) Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee |
| 2 | Common | Common Stock | 2025-12-05 | C | A | 98 | $0.00 | 109 | I | — | — | |
| 3 | Common | Common Stock | 2025-12-05 | C | A | 12,064 | $0.00 | 13,799 | D See Footnote | — | — | (F1) Shares held by a partnership of which the reporting person is the managing member of the managing partner |
| 4 | Derivative | Series X Convertible Preferred Stock | 2025-12-05 | C | D | 5,860.54 | $0.00 | 0 | I See Footnote | $0.00 · 2025-12-05 to — | 0 Common Stock | (F2) Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee (F3) Series X Convertible Preferred Stock has no expiration date |
| 5 | Derivative | Series X Convertible Preferred Stock | 2025-12-05 | C | D | 18.69 | $0.00 | 0 | I | $0.00 · 2025-12-05 to — | 0 Common Stock | (F3) Series X Convertible Preferred Stock has no expiration date |
| 6 | Derivative | Series X Convertible Preferred Stock | 2025-12-05 | C | D | 2,292.34 | $0.00 | 0 | D See Footnote | $0.00 · 2025-12-05 to — | 0 Common Stock | (F1) Shares held by a partnership of which the reporting person is the managing member of the managing partner (F3) Series X Convertible Preferred Stock has no expiration date |